CTRM
Castor Maritime Inc.
There isn't enough reported data to score CTRM yet.
CTRM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
CTRM's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CTRM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 0.4x | $1.31 | โ |
| Cheap | 0.5x | $1.82 | +39% |
| Fair | 1x | $3.44 | +163% |
| Expensive | 1.9x | $6.31 | +382% |
Historical ranges are pointers, not guarantees.
CTRM's PE is 0.4x, but its earnings don't support one, so it isn't a reliable read right now.
CTRM Forward outlook
There aren't enough analyst estimates for CTRM to show an outlook.
CTRM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.32 | +$6.89 |
| Q4 2025 | $0.36 | -5.3% |
| Q4 2024 | $0.38 | -78% |
| Q4 2023 | $1.70 | -86% |
| Q2 2023 | $9.50 | +9.2% |
| Q4 2022 | $12.50 | +166% |
CTRM's earnings per share have fallen from their peak: $3.32 over the past year, against $12.50 in late 2022.
CTRM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $46.8M | +22% |
| Q4 2025 | $43.5M | +47% |
| Q2 2025 | $38.3M | +4.4% |
| Q4 2024 | $29.6M | -70% |
| Q2 2024 | $36.7M | -26% |
| Q4 2023 | $97.5M | -30% |
| Q2 2023 | $49.7M | -59% |
| Q4 2022 | $140M | +36% |
CTRM's revenue is recovering but still below its 2022 peak: $47M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 156% | +81 points |
| Q4 2025 | 36% | +14 points |
| Q2 2025 | -90% | -111 points |
| Q4 2024 | -20% | -74 points |
| Q2 2024 | 75% | +33 points |
| Q4 2023 | 23% | -23 points |
| Q2 2023 | 22% | -8 points |
| Q4 2022 | 54% | +65 points |
CTRM's operating margin was 156% last quarter, up 81 points from the same quarter a year ago, near the top of its range since 2018.
CTRM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$62.8M | -$58.6M |
| Q4 2025 | $13.6M | +$67.7M |
| Q2 2025 | -$4.2M | -118% |
| Q4 2024 | -$54.1M | -351% |
| Q2 2024 | $23.8M | +186% |
| Q4 2023 | $21.6M | +22% |
| Q2 2023 | $8.3M | -72% |
| Q4 2022 | $17.6M | +$64.4M |
CTRM's free cash flow was โ$108M over the past year, against $71M the year before.
CTRM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -0.6x | Net Cash |
| Q2 2023 | 0.8x | Very low |
| Q4 2022 | 0.1x | Very low |
| Q2 2022 | 0.3x | Very low |
| Q4 2021 | 0.9x | Very low |
| Q2 2021 | 0.3x | Very low |
| Q4 2020 | 1.8x | Healthy |
CTRM has more cash than debt.
CTRM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 4.8 | Oversold |
CTRM's weekly RSI is 29 (oversold) and its Stochastic is 5 (oversold).
CTRM PE vs Industrials Sector
| Metric | CTRM | Sector median | Relative |
|---|---|---|---|
| PE | 0.4x | 24x | 98% below |
| PE % | 1 | 59 | 58 pts below |
CTRM is trading at 0.4x earnings, a 98% discount to the Industrials sector's median of 24x, though its earnings don't support one.
CTRM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.65 | 21% below |
| 20 week MA | $1.98 | 34% below |
| 50 week MA | $2.04 | 36% below |
| 100 week MA | $2.17 | 40% below |
CTRM is in a downtrend: it's below all four of its weekly moving averages, and 40% below its 100-week average.
CTRM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $8.84 | $4.25 | -52% |
| 2024 | $4.25 | $2.88 | -32% |
| 2025 | $2.88 | $2.32 | -19% |
| 2026 YTD | $2.32 | $1.31 | -44% |
CTRM has finished every year since 2023 lower, and it's down 44% so far in 2026.